Skip to main content

Webinars & Symposiums

All the contents referenced below are NOT owned by bioMérieux. Please note that by clicking on a link you will be redirected outside bioMérieux's website.

Time to shift gears with AKI biomarkers

Time to shift gears with AKI biomarkers

This symposium during the 2022 Vicenza Course on AKI & CRRT covers AKI awareness challenges and opportunities and discusses AKI biomarkers as new tools for decision making.

This symposium was supported by bioMérieux.

AKI Awareness – The Blind Spots Driving Poor Outcome

AKI Awareness – The Blind Spots Driving Poor Outcome

This symposium during the 39th Vicenza Course on AKI & CRRT provides understanding related to the gaps of knowledge of non-AKI focused Health Care Providers which may identify opportunities to raise AKI awareness.

This symposium was supported by bioMérieux.

Acute Kidney Injury - What is on the horizon?

Acute Kidney Injury - What is on the horizon?

Join the Intensive Care Society on a webinar that focuses on AKI and the role of AKI biomarkers in clinical practice.

This webinar is supported by an educational grant from bioMérieux.

The use of biomarkers in the management of AKI: AKI in the critically ill

The use of biomarkers in the management of AKI: AKI in the critically ill

This webinar features 2 speakers. Prof. Lui G. Forni (Consultant Intensivist & Nephrologist from Royal Surrey County Hospital NHS Foundation Trust, UK), lays the foundation of the importance of using biomarkers in the management of AKI in the critically ill. Dr. Daniel Engelman (Cardiac Surgeon from Baystate Medical Center, USA) discusses how biomarkers play a role in preventing cardiac surgery-associated AKI.

This webinar was supported by an educational grant from bioMérieux and Ortho Clinical Diagnostics.

KDIGO AKI & COVID-19

KDIGO AKI & COVID-19

The KDIGO (Kidney Disease: Improving Global Outcomes) AKI & COVID-19 webinar held in September 2020, featuring Prof. John Kellum from University of Pittsburgh, USA and Dr. John Prowle from Queen Mary University in London, UK, examines the complexity of treating AKI in the context of SARS-CoV-2 infection.

This webinar was supported by an educational grant from bioMérieux.

The scientific content in the above materials has been developed independently by the speaker(s)/author(s). The views presented in these materials are the authors’ personal opinions and do not necessarily represent the viewpoint, strategy or opinions of bioMérieux.

The content on this website and associated materials do not constitute medical advice and should not be considered a substitute for the individual professional judgement of any physician or other health care practitioner regarding the appropriate course of action for a particular patient. All recommendations should be independently reviewed with appropriate medical staff in light of the needs of any particular institution and its patients. bioMérieux makes no guarantee or representation regarding the accuracy, completeness, or usefulness of this information for any particular purpose, including but not limited to any cost savings.

Discover other educational resources: